Literature DB >> 6831225

Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF.

W B Mens, A Witter, T B van Wimersma Greidanus.   

Abstract

The penetration of neurohypophyseal peptides after peripheral administration into the cerebrospinal fluid (CSF) was studied in freely moving rats. In addition, the clearance of these peptides from CSF was investigated. Increased concentrations of vasopressin (AVP) in CSF were detectable 2 min after s.c. injection of 5.0 micrograms of this peptide. Peak concentration was reached at 5 min after administration and this level declined slowly over the next hour. Administration of 5.0 micrograms oxytocin (OXT) s.c. or i.v. resulted in increased OXT levels in CSF within 10 min after application. After 60 min a significant elevation of OXT in CSF was no longer present. These data reveal that approximately 0.002% of the peripherally applied amount of AVP or OXT reached the central nervous system at 10 min after injection. AVP (2.5 ng) and OXT (5.0 ng) applied into one of the lateral brain ventricles reached the cisternal cavity within 2 min after administration. Both neuropeptides were cleared from the CSF with terminal half-times of 26 and 19 min for AVP and OXT, respectively. The present data demonstrate that neurohypophyseal hormones do cross the blood-brain barrier in amounts obviously sufficient to induce central actions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831225     DOI: 10.1016/0006-8993(83)90478-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  93 in total

Review 1.  Premature ejaculation: definition and drug treatment.

Authors:  Marcel D Waldinger
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Oxytocin delivered nasally or intraperitoneally reaches the brain and plasma of normal and oxytocin knockout mice.

Authors:  Adam S Smith; Austin C Korgan; W Scott Young
Journal:  Pharmacol Res       Date:  2019-06-22       Impact factor: 7.658

Review 3.  Delivering peptides to the central nervous system: dilemmas and strategies.

Authors:  W A Banks; A J Kastin; C M Barrera
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

4.  Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat.

Authors:  J R Seckl; S L Lightman
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

5.  Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks.

Authors:  Sook Jin Son; Jessica A Filosa; Evgeniy S Potapenko; Vinicia C Biancardi; Hong Zheng; Kaushik P Patel; Vicky A Tobin; Mike Ludwig; Javier E Stern
Journal:  Neuron       Date:  2013-06-19       Impact factor: 17.173

Review 6.  Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression.

Authors:  M R Lee; R D Jayant
Journal:  Cell Tissue Res       Date:  2018-12-10       Impact factor: 5.249

Review 7.  Oxytocin Modulation of Neural Circuits.

Authors:  Mariela Mitre; Jessica Minder; Egzona X Morina; Moses V Chao; Robert C Froemke
Journal:  Curr Top Behav Neurosci       Date:  2018

8.  WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action.

Authors:  Callum Hicks; Linnet Ramos; Tristan A Reekie; Rajeshwar Narlawar; Michael Kassiou; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2015-03-13       Impact factor: 4.530

9.  Social Cognition and Oxytocin in Huntington's Disease: New Insights.

Authors:  Elisa Unti; Sonia Mazzucchi; Daniela Frosini; Cristina Pagni; Gloria Tognoni; Lionella Palego; Laura Betti; Fabiana Miraglia; Gino Giannaccini; Roberto Ceravolo
Journal:  Brain Sci       Date:  2018-08-26

Review 10.  Putative roles of neuropeptides in vagal afferent signaling.

Authors:  Guillaume de Lartigue
Journal:  Physiol Behav       Date:  2014-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.